Lincoln National Corp T2 Biosystems, Inc. Transaction History

Lincoln National Corp

  • $3.11 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 05, 2021
SELL
$1.06 - $1.51 $10,600 - $15,100
-10,000 Closed
0 $0
Q3 2020

Nov 09, 2020
BUY
$1.15 - $2.1 $11,500 - $21,000
10,000 New
10,000 $14,000

About T2 Biosystems, Inc.

TTOO Quotes by TradingView
  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $5.99M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email